PURE Bioscience Appoints Peter C. Wulff as Chief Financial Officer

PURE Bioscience Appoints Peter C. Wulff as Chief Financial Officer

[at noodls] – SAN DIEGO, (November 8, 2012) — PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has named Peter C. Wulff as Chief Financial … more

View todays social media effects on ATEC

View the latest stocks trending across Twitter. Click to view dashboard

Share this post